SPARC enters into licensing agreement with Biomodifying

03 Dec 2021 Evaluate

Sun Pharma Advanced Research Company (SPARC) has entered into an agreement with Biomodifying LLC (Biomodifying) to exclusively license Biomodifying’s intellectual property, including all patents and patent applications owned or controlled by Biomodifying, along with antibodies developed for multiple uses including for cancer.

Under the agreement, Biomodifying is eligible for an up-front payment, milestone payments on pre-specified clinical, regulatory, and commercial milestones, as well as royalties on sales. In addition, SPARC will pay Biomodifying a percentage of payments received for sublicenses of the licensed IP.

SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Sun Pharma Adv. Res Share Price

133.60 -0.15 (-0.11%)
30-Dec-2025 14:49 View Price Chart
Peers
Company Name CMP
Syngene Internation. 645.35
Indegene 520.90
CMS Info Systems 340.40
Sagility 52.38
Smartworks Coworking 475.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×